På PAUL HARTMANN AG i Heidenheim/Tyskland, somdär alla koncernens aktiviteter styrs, är vi fast beslutna att skapa innovativa vårdlösningar som gynnar både vårdgivare och patienter över hela världen. Vår styrelse har en modern framåtblickande syn på verksamheten och använder expertis och kunskap som förvärvats under företagets nästan 200-åriga historia för att sätta agendan för framtidens hälso- och sjukvård.
För att stötta kollegorna i Tyskland finns ett globalt nätverk med HARTMANN-representanter
Ta reda på mer om våra värderingar
Styrelsen
Meet our Management Board
Chairman of the Management Board (CEO)
Britta Fünfstück
Physicist Britta Fünfstück is the head of the HARTMANN GROUP. She is responsible for corporate strategy, the Transformation Program office, the Infection Management segment with the Risk Prevention and Disinfection divisions and the KNEIPP subsidiary. Her responsibilities also include the German domestic market as well as the Pharmacy business, Digital, Human Resources, Communications, Quality Management and Compliance.
Member of the Management Board
François Georgelin
Biomedical engineer François Georgelin is responsible for the Wound Care segment, Regulatory Affairs and the KOB subsidiary. He is also in charge of commercial operations for Northern and Eastern Europe along with France, South America and the USA.
Member of the Management Board
Stefan Grote
Der Betriebswirt Stefan Grote verantwortet das Segment Inkontinenzmanagement sowie die Bereiche Einkauf, Supply Chain, Real Estate, Nachhaltigkeit, Online- und E-Commerce. Zudem leitet er die Marktaktivitäten in West- und Südeuropa, Asien, Australien, Afrika und im Mittleren Osten.
Member of the Management Board (CFO)
Oliver Neubrand
Business graduate Oliver Neubrand took over as CFO on January 1, 2024, and is responsible for Controlling, Finance, Accounting, Mergers & Acquisitions, Internal Audit, Risk Management, Legal, IT, Investor Relations as well as the CMC subsidiary and IVF HARTMANN business activities in Switzerland.
